Literature DB >> 17594692

Patients with previous cancer should not be excluded in international comparative cancer survival studies.

Hermann Brenner1, Timo Hakulinen.   

Abstract

In international comparisons or time trend analyses of cancer survival, it is common practice to restrict analyses to patients with a first cancer, i.e., to exclude patients with previous cancer diagnoses. However, the proportion of cancer patients with known previous cancer depends on the time cancer registries have been running, which results in varying proportions of excluded patients across registries. If prognosis of patients with second cancers differs from prognosis of patients with first cancers, varying exclusions may bias survival comparisons. We empirically evaluate the dependence of proportions of patients recorded as having a first cancer on time since initiation of cancer registration and the impact of excluding patients with known previous cancer on cancer survival estimates using the data of the nationwide Finnish Cancer Registry. Among 20 common cancer sites investigated, the proportion of "first cancers" varied between 97.4 and 99.7% in 1953-1957, the first 5-years of cancer registration, and decreased continuously to levels between 83.9 and 92.7% in 1993-1997. Excluding patients with a previous cancer diagnosis had little impact on estimates of survival of cancer patients diagnosed in 1953-1957, but increased 5-year relative survival estimates among patients diagnosed in 1993-1997 for each of the 20 cancers. The extent of the increase varied by cancer site and age. The increase ranged up to 2.9% points for crude and up to 1.7% points for age adjusted 5-year relative survival. These results caution against exclusion of patients with previous cancer diagnosis in comparative analyses of cancer survival. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17594692     DOI: 10.1002/ijc.22932

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  A further caveat in interpreting cancer survival.

Authors:  Stefano Rosso; Roberto Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2010-04       Impact factor: 66.675

2.  Relative survival analysis using the Centers for Disease Control and Prevention's National Program of Cancer Registries Surveillance System Data, 2000-2007.

Authors:  Reda J Wilson; A Blythe Ryerson; Kevin Zhang; Xing Dong
Journal:  J Registry Manag       Date:  2014

3.  Development of National Program of Cancer Registries SAS Tool for Population-Based Cancer Relative Survival Analysis.

Authors:  Xing Dong; Kevin Zhang; Yuan Ren; Reda Wilson; Mary Elizabeth O'Neil
Journal:  J Registry Manag       Date:  2016

4.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

5.  Evaluation of North American Association of Central Cancer Registries' (NAACCR) data for use in population-based cancer survival studies.

Authors:  Hannah K Weir; Christopher J Johnson; Angela B Mariotto; Donna Turner; Reda J Wilson; Diane Nishri; Kevin C Ward
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

6.  Impact of including second and later cancers in cause-specific survival estimates using population-based registry data.

Authors:  Gonçalo Forjaz; Nadia Howlader; Steve Scoppa; Christopher J Johnson; Angela B Mariotto
Journal:  Cancer       Date:  2021-10-08       Impact factor: 6.921

7.  The effect of multiple primary rules on population-based cancer survival.

Authors:  Hannah K Weir; Christopher J Johnson; Trevor D Thompson
Journal:  Cancer Causes Control       Date:  2013-04-05       Impact factor: 2.506

8.  Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets.

Authors:  L Elliss-Brookes; S McPhail; A Ives; M Greenslade; J Shelton; S Hiom; M Richards
Journal:  Br J Cancer       Date:  2012-09-20       Impact factor: 7.640

9.  Methodological issues in estimating survival in patients with multiple primary cancers: an application to women with breast cancer as a first tumour.

Authors:  Stefano Rosso; Fulvio Ricceri; Lea Terracini; Roberto Zanetti
Journal:  Emerg Themes Epidemiol       Date:  2009-02-27

10.  The effect of multiple primary rules on cancer incidence rates and trends.

Authors:  Hannah K Weir; Christopher J Johnson; Kevin C Ward; Michel P Coleman
Journal:  Cancer Causes Control       Date:  2016-01-25       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.